Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of RNA-modulating drugs in the United States. The company develops ELX-02, which is in phase II clinical trial for the treatment of nonsense mutation alport syndrome; ZKN013, which is in investigation phase for the treatment of nonsense mutation recessive dystrophic and junctional epidermolysis bul… Read more
Market Cap & Net Worth: Eloxx Pharmaceuticals Inc (ELOX)
Eloxx Pharmaceuticals Inc (PINK:ELOX) has a market capitalization of $314.34 ($314.34) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #49404 globally and #15125 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eloxx Pharmaceuticals Inc's stock price $0.00 by its total outstanding shares 3143390 (3.14 Million).
Eloxx Pharmaceuticals Inc Market Cap History: 2015 to 2025
Eloxx Pharmaceuticals Inc's market capitalization history from 2015 to 2025. Data shows change from $1.00 Billion to $314.34 (-80.17% CAGR).
Eloxx Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eloxx Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4700.83x
Eloxx Pharmaceuticals Inc's market cap is 4700.83 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.00 Billion | $75.00K | -$18.06 Million | 13378.27x | N/A |
| 2016 | $352.56 Million | $75.00K | -$8.27 Million | 4700.83x | N/A |
Competitor Companies of ELOX by Market Capitalization
Companies near Eloxx Pharmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Eloxx Pharmaceuticals Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Eloxx Pharmaceuticals Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Eloxx Pharmaceuticals Inc's market cap moved from $1.00 Billion to $ 314.34, with a yearly change of -80.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $314.34 | -99.99% |
| 2023 | $3.77 Million | -34.07% |
| 2022 | $5.72 Million | -93.56% |
| 2021 | $88.79 Million | -82.26% |
| 2020 | $500.43 Million | -45.92% |
| 2019 | $925.41 Million | -38.72% |
| 2018 | $1.51 Billion | +50.12% |
| 2017 | $1.01 Billion | +185.31% |
| 2016 | $352.56 Million | -64.86% |
| 2015 | $1.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Eloxx Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $314.34 USD |
| MoneyControl | $314.34 USD |
| MarketWatch | $314.34 USD |
| marketcap.company | $314.34 USD |
| Reuters | $314.34 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.